Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
David Desplas
EPI-PHARE, France
Poster(s):
(CSPOT40) Use and Outcomes of Trastuzumab Deruxtecan in HER2-positive and HER2-low Metastatic Breast Cancer in Real-World Setting: A Nationwide Cohort Study
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST